CV Lattes
ORCID
Google Scholar Citations
Universidade Estadual de Campinas (UNICAMP). Faculdade de Ciências Farmacêuticas (FCF) (Institutional affiliation from the last research proposal) Birthplace: Brazil
Post-doctorate at the University of Gothenburg, Department of Clinical Neurosciences and Physiology, Sahlgrenska Academy, Sweden (2014) and State University of Campinas (UNICAMP) (2015); Master (2006) and PhD (2009) in Cellular and Structural Biology (UNICAMP - CAPES 6), with emphasis in Tissue Biology. Develops projects mainly in the field of Pharmacology, focusing on translational research, specifically on the development of immunomodulatory drugs with therapeutic potential in inflammatory, neurodegenerative, autoimmune and cancer diseases. It has experience in microscopic, morphophysiological and molecular analyzes of cells and tissues. It is a member of the editorial board/reviewer of 17 international Journals and is a reviewer of Elsevier. It has 2 chapters of books and 20 articles published in international journals. Currently it is coordinator of projects funded by the Brazilian Foundations, FAPESP (2015/04194-0) and CNPq (431465/2016-9), including research grants and scholarships (Project: Identification of new molecules with chemotherapeutic effect in glioma and characterization of its mechanism of action). Supervises 2 PhD's, 4 master's degrees, and 2 undergraduate students, and 1 technical training. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
I. Overview: The use of products of natural origin is considered strategic in the context of cancer treatment. It was recently demonstrated that components of the venom of the Phoneutria nigriventer (PnV) spider have antitumor effects in vitro and in vivo models, with emphasis on the modulation of the immune response against glioblastomas. Recently, the composition containing dendritic ce…
Malignant brain tumors are among the most devastating types of human cancer. The ability to invade healthy neural tissue is a characteristic of gliomas that makes the treatment difficult. The PI3K/Akt/mTOR (and the PTEN phosphatasis, which innactivates that pathway) and RhoA/ROCK pathways and the Na+/K+-ATPase pump are involved in the tumorigenesis, migration, invasion, growth and surviva…
Severe accidents caused by the "armed" spider Phoneutria nigriventer causeneurotoxic manifestations in victims. In experiments with rats, P. nigriventer venom(PNV) temporarily disrupts the properties of the blood brain barrier (BBB) by affecting both the transcellularand the paracellular route. However, it is unclear how cells and/or proteins participatein the transient opening of the BBB…
Breast cancer is the second most common neoplasm in women (second only to non-melanoma skin tumors). The treatment of this disease presents several clinical challenges, such as its high mortality rate and the use of medications that have several adverse effects. Given the need for more specific and less toxic therapies, the use of natural substances, such as animal venoms, appears to be a…
I. Overview: Gliomas account for approximately 80% of brain tumors malignant primaries in adults. Mainly due to its invasiveness, characterized byhigh ability to migrate and invade healthy brain substance, these are tumors that are difficult totreatment, being responsible for the majority of deaths associated with brain cancer. He wasrecently demonstrated by our research group that the ve…
Gliomas account for approximately 80% of primary malignant brain tumors in adults. The highly infiltrating and aggressive glioblastoma subtype (grade IV) corresponds to an average patient survival around 15 months after diagnosis. Advances in knowledge of new therapeutic options have not yet significantly improved the survival of these patients, who are currently treated using surgical re…
Gliomas correspond to approximately 80% of primary malignant brain tumors in adults. Until recently, these tumors were classified mainly on the basis of histopathological criteria; however, associating these aspects to the identification of the molecular profile of the neoplasias has been shown to be a more accurate strategy in relation to the prediction of the tumor's behavior and its re…
Immuno-oncology is an emerging field that is revolutionizing the treatment of cancer. Although most immunomodulatory strategies have focused on increasing T cell response, there has been a recent increase in the interest in the natural killer (NK) cell compartment. Clinical responses to NK cell-based adoptive immunotherapy, however, were thwarted by the profound immunosuppression induced …
(Only some records are available in English at this moment)
Malignant gliomas are the most common primary brain tumors in adults. Characterized by their high diffusion through the brain parenchyma, these tumors are associated with a poor prognosis. Glioblastoma (GB), the most aggressive type, has a survival rate of less than two years post-diagnosis. Current treatments, including surgery, radiotherapy, and chemotherapy, are often insufficient due …
Gamma delta T cells hold great promise for cancer immunotherapy, as they display broad tumor reactivity, and recognize tumor cells independently of both mutational load and human leukocyte antigen (HLA)-mediated antigen presentation. Our laboratory has established a clinical-grade protocol allowing robust expansion and differentiation of anti-tumor V delta 1+ T cells (termed Delta One T/ …
Parkinson's disease (PD) is a neurodegenerative condition that affects the Central Nervous System. It is an idiopathic degeneration and touches about 1% of the elderly population over the age of 60 worldwide. As the epidemiological profile of the population is changing, with a large increase in the number of elderly people, PD is also more common and research to understand the condition a…
Immunomodulation has been considered an established antitumor approach, since immune cells, mainly macrophages, are involved in tumorigenesis. The tumor microenvironment infiltrating cells include regulatory lymphocytes and myeloid cells, represented by different populations of macrophages known as tumor-associated macrophages (TAMs). Although they show a complex phenotypic and behavioral…
(Only some records are available in English at this moment)
| 6 / 3 | Completed research grants |
| 2 / 2 | Ongoing scholarships in Brazil |
| 11 / 10 | Completed scholarships in Brazil |
| 1 / 1 | Ongoing scholarships abroad |
| 4 / 4 | Completed scholarships abroad |
| 24 / 20 | All research grants and scholarships |
| Associated processes | |